Ceftriaxone-associated	ceftriaxone-associated	O	O	O	O
biliary	biliary	O	O	OTHERS	I
pseudolithiasis	pseudolithiasis	O	DISEASE	OTHERS	I
in	in	O	O	O	O
paediatric	paediatric	O	O	O	O
surgical	surgical	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
well	well	O	O	O	O
known	known	O	O	O	O
that	that	O	O	O	O
ceftriaxone	ceftriaxone	CHEMICALS	O	OTHERS	I
leads	leads	O	O	O	O
to	to	O	O	O	O
pseudolithiasis	pseudolithiasis	O	DISEASE	OTHERS	I
in	in	O	O	O	O
some	some	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

Clinical	clinical	O	O	O	O
and	and	O	O	O	O
experimental	experimental	O	O	O	O
studies	studies	O	O	O	O
also	also	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
situations	situations	O	O	O	O
causing	causing	O	O	O	O
gallbladder	gallbladder	O	O	OTHERS	I
dysfunction	dysfunction	O	O	OTHERS	I
,	,	O	O	O	O
such	such	O	O	O	O
as	as	O	O	O	O
fasting	fasting	O	O	O	O
,	,	O	O	O	O
may	may	O	O	O	O
have	have	O	O	O	O
a	a	O	O	O	O
role	role	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
pseudolithiasis	pseudolithiasis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
prospectively	prospectively	O	O	O	O
evaluated	evaluated	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
and	and	O	O	O	O
clinical	clinical	O	O	O	O
importance	importance	O	O	O	O
of	of	O	O	O	O
pseudolithiasis	pseudolithiasis	O	DISEASE	OTHERS	I
in	in	O	O	O	O
paediatric	paediatric	O	O	O	O
surgical	surgical	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
ceftriaxone	ceftriaxone	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
,	,	O	O	O	O
who	who	O	O	O	O
often	often	O	O	O	O
had	had	O	O	O	O
to	to	O	O	O	O
fast	fast	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
post-operative	post-operative	O	O	O	O
period	period	O	O	O	O
.	.	O	O	O	O

Fifty	fifty	O	O	O	O
children	children	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
given	given	O	O	O	O
ceftriaxone	ceftriaxone	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
evaluated	evaluated	O	O	O	O
by	by	O	O	O	O
serial	serial	O	O	O	O
abdominal	abdominal	O	O	O	O
sonograms	sonograms	O	O	O	O
.	.	O	O	O	O
Of	of	O	O	O	O
those	those	O	O	O	O
,	,	O	O	O	O
13	13	O	O	O	O
(	(	O	O	O	O
26	26	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
developed	developed	O	O	O	O
biliary	biliary	O	O	O	O
pathology	pathology	O	O	O	O
.	.	O	O	O	O

Comparison	comparison	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
or	or	O	O	O	O
without	without	O	O	O	O
pseudolithiasis	pseudolithiasis	O	DISEASE	OTHERS	I
revealed	revealed	O	O	O	O
no	no	O	O	O	O
significant	significant	O	O	O	O
difference	difference	O	O	O	O
with	with	O	O	O	O
respect	respect	O	O	O	O
to	to	O	O	O	O
age	age	O	O	O	O
,	,	O	O	O	O
sex	sex	O	O	O	O
,	,	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
and	and	O	O	O	O
starvation	starvation	O	O	O	O
variables	variables	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
cessation	cessation	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
,	,	O	O	O	O
pseudolithiasis	pseudolithiasis	O	DISEASE	OTHERS	I
resolved	resolved	O	O	O	O
spontaneously	spontaneously	O	O	O	O
within	within	O	O	O	O
a	a	O	O	O	O
short	short	O	O	O	O
period	period	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
pseudolithiasis	pseudolithiasis	O	DISEASE	OTHERS	I
is	is	O	O	O	O
not	not	O	O	O	O
affected	affected	O	O	O	O
by	by	O	O	O	O
fasting	fasting	O	O	O	O
.	.	O	O	O	O

